When IVIg can not be accessed under the National arrangements, if the clinician considers that the patient would benefit from IVIg therapy, the clinician may still obtain IVIg through the Jurisdictional Direct Order (JDO) provision. Note that procedures for accessing IVIg JDO arrangements will vary and only imported IVIg is available under JDO arrangements.

In most states/territories, IVIg is ordered from TMS (Transfusion Medicine Services) at the ARCBS. Distribution procedures from the ARCBS vary slightly between jurisdictions, but this will not change as a result of the introduction of the Criteria.

Patients in need of financial assistance are eligible to receive up to $1,000 over a one-year period while undergoing treatment.

It is recommended that the patient start treatment with Vivaglobin® one week after receiving a regularly scheduled IVIg infusion. The initial weekly Vivaglobin® dose can be calculated by multiplying the previous IVIg dose by 1.37, then dividing this dose into weekly doses based on the patient's previous IVIg treatment interval; for example, if IVIg was administered every three weeks, divide by 3.

If it is to an in-house nursing unit, there are recent studies that suggest patients can be discharged when the following criteria are met: sensory blockade lower than T10, minimal movement of the lower extremities, and no need for fluid resuscitation. However, most of us are still following the standard discharge criteria of stable adult patients, able to stand, walk and void following spinal anesthesia if they are going home or to another nursing unit.

HRTP is open to currently enrolled as matriculated undergraduate, graduate, and professional students in a degree program at an accredited college or university. Recent graduates are not eligible unless they will be enrolled as matriculated student in a degree program at an accredited institution. (i.e. If a student is graduating from college in May 2007, s/he is only eligible if matriculated in a degree program in Fall 2007.) Applicants must be in good academic standing.

Neonatal haemochromatosis, toxic epidermal necrolysis/Steven Johnson syndrome and toxic shock syndrome are important new conditions for funded IVIg. IVIg is also now available for use in the treatment of severe relapsing-remitting multiple sclerosis during pregnancy and in cases unresponsive to standard therapies. Multiple sclerosis was formerly a Category 3 indication in the 2000 guidelines.

IVIG is a treatment for many immune disorders. Preliminary research suggests that it may help maintain pregnancy in women who have experienced secondary recurrent miscarriage by improving the mother’s immune response to this pregnancy. Currently, Dr. Stephenson is conducting an international trial to test whether IVIG helps promote successful pregnancies in women who have suffered secondary recurrent miscarriage.

Are there any specific medication safety concerns with regard to prophylaxis and treatment of bioterror-associated infections in children? STRATEGIC NATIONAL STOCKPILE

Firstly, an increased number and broader range of conditions are considered. Ninety-four conditions or groups of conditions are considered. The Criteria describes 12 conditions for which IVIg use has an established therapeutic role; 22 for which IVIg has an emerging therapeutic role; and 25 for which IVIg should be used in exceptional circumstances only, such as in urgent or life-threatening circumstances.

The priority of IVIg use has been reduced in favour of alternative therapies and is now considered exceptional practice for the treatment of acute childhood leukemia and, with the advent of antiretroviral therapy, paediatric cases of HIV infection. Also, a number of conditions that were classified as Category 2 indications in the 2000 guidelines have been assessed as ‘non-indications’ in the Criteria.

All of your questions related to the Patient Management Tool -- including registration, requirements, training, security and cost -- can be found on the PMT FAQ.

In an overwhelming pandemic with a severe shortage of ventilators and staff to operate them, access to ventilators would depend only on clinical factors, primarily, which patients have the greatest medical need—and the best chance of survival—if they receive ventilator support.

Access to ventilators would be limited based on clinical factors that pose the highest probability of mortality, such as: cardiac arrest; end stage organ failure; severe irreversible neurologic condition with high risk of death; metastatic cancer with high risk of death. Age, non-life threatening disability and "social worth" are NOT exclusion criteria. NO. Physicians would be expected to provide care, as always, and to put their patients' interests first.

Several conditions must be met before the Emory libraries will consider subscribing to an e-only journal. The first four conditions below are requirements; the last two conditions are strongly desired: Use of online content: the license terms grant the right for Authorized Users to print and download articles in reasonable quantity from the online version. In addition, the design of the publisher's website allows for printing from a PDF file.

Go to our homepage and click on our “Links” section, or follow this link. You will find a number of resources that may be useful to you. Support groups for a number of diseases (e.g., cancer, diabetes, Down's syndrome, heart disease, hemophilia), information on the March of Dimes, and the National Organization for Rare Disorders are just a few examples. Also under “Links” on our homepage, look at “Federal Agencies.

The state will maintain a confidential list of “qualified patients” and “approved caregivers” to whom the department has issued registry identification cards.

You choose which two of the patient’s eligible conditions to submit. Review the list of diagnostic codes provided and choose the one that reflects the two eligible conditions you wish to submit. Before doing so, it would be advisable to review the criteria of Option 1 and Option 2 below. Under Option 1, the Fee for Service option, visits provided for conditions other than the two chosen would not qualify for access to the complex care fee.

Patient Assistance Program: Eligibility and application requirements vary by company so an applicant typically has to apply to each program separately. To find a list of manufacturers and medications available click here.

Controlling your diet, regular exercise and taking your medication regularly are all steps you can take to prevent the situation from getting worse.

If the patient's condition improves and the disease seems to be in remission, Hospice will discharge the patient and he or she may receive other medical care. If a discharged patient should later need to return to hospice care, the patient can be readmitted to the program.

YES. We can provide you with secure access to view your patient's images via the Internet 24 hours a day, 365 days a year. No more carrying films with you or waiting to see images, they are available immediately after the scan is completed.

Yes. Using a static IP address for security, you can retrieve and amend patient data from any location in the world that has internet connectivity.

You can get access to the RAMRS system used at Clarian Hospitals by completing a form in the Medical Science Building, Room 159. Your account will be de-activated after 90 days of non-use. You can get your account re-activated by calling Data Security at Methodist Hospital at 929-2828.

The criteria that determines preliminary eligibility is as such: the female partner must be under age 38 at the time of the egg retrieval(s), the female can not have had a previously unsuccessful in-vitro fertilization (IVF) cycle, the female Body Mass Index (BMI) must be under 30, and her Follicle stimulating hormone (FSH) test under 10. If you meet these criteria, you are eligible to enter the program and begin the prescreening process.

Students must be enrolled in a degree or certificate program and have a complete admissions status including all transcripts prior to receiving aid. Students must meet satisfactory progress standards, which are explained on our website. Students must have eligibility for federal financial aid as determined by the federal processor on the SAR (Student Aid Report). Financial aid will be awarded to students based on their enrollment status.

There are many factors to consider in addition to price when selecting an installer. In addition to soliciting price quotes, you should also consider location, experience (both in years and number of completed projects), certification (e.g. NABCEP), average installation timeframe, and company size. You should also request a minimum of three customer references from previous installations.

The guidelines for hospice eligibility have been adopted by Medicare hospice intermediary, so can be found on its Web sites at: http://www.ugsmedicare.com/providers/lmrp/documents/Hospice%20LCD%2001-01-04.pdf. In addition, these guidelines are available in PDA format at www.infingo.com/mninfo.htm. You have to also download the reader to view the content on Palm or Windows PC PDAs (Free).

IVIG has been shown to be beneficial in the treatment of several immune regulation disorders. Extensive evidence exists suggesting that immunoregulatory mechanisms are involved in MS. Several possible mechanisms by which IVIG improves the course of the disease are related to limiting the inflammatory process and repairing the damage to the myelin sheath by enhancing remyelination. Presently, the evidence through research supports that IVIG is beneficial for patients with MS.